MATINAS BIOPHARMA HLDGS INC - COM (MTNB)

CUSIP: 576810105

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
27,155,185
Share change
-488,091
Total reported value
$13,575,184
Price per share
$0.50
Number of holders
55
Value change
-$264,022
Number of buys
18
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 576810105?
CUSIP 576810105 identifies MTNB - MATINAS BIOPHARMA HLDGS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MATINAS BIOPHARMA HLDGS INC - COM (MTNB) as of Q4 2022

As of 31 Dec 2022, MATINAS BIOPHARMA HLDGS INC - COM (MTNB) was held by 55 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,155,185 shares. The largest 10 holders included VANGUARD GROUP INC, Sargent Investment Group, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NEVILLE RODIE & SHAW INC, Arkadios Wealth Advisors, JTC Employer Solutions Trustee Ltd, STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and LPL Financial LLC. This page lists 55 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.